Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)

Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

(2013) Jan-Christian Reil et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of If-Channel Inhibition on Hemodynamic Status and Exercise Tolerance in Heart Failure With Preserved Ejection Fraction

(2013) Wojciech Kosmala et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction

(2012) Jan-Christian Reil et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)

(2012) Kazuhiro Yamamoto et al.   EUROPEAN JOURNAL OF HEART FAILURE

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

(2012) Davide Castagno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

(2010) Michel Komajda et al.   Circulation-Heart Failure

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction

(2010) Micha T. Maeder et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function

(2010) John R. Kapoor et al.   JOURNAL OF CARDIAC FAILURE

Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction

(2010) Barry A. Borlaug et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

(2010) Michael Böhm et al.   LANCET

Impaired Heart Rate Recovery and Chronotropic Incompetence in Patients With Heart Failure With Preserved Ejection Fraction

(2009) Thanh Trung Phan et al.   Circulation-Heart Failure

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

(2009) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial

(2008) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: The DIAMOND study

(2008) Emil Loldrup Fosbøl et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE